《Table 3Cost-effective of the multimodal group and control group.》
提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma》
No patient was excluded from this study after the grouping and selection for this study(Fig.1).Characteristics and perioperative data of the 84 patients were summarized in Table 1.There was no significant difference in age,gender,the purpose of TACE,ChildPugh class,duration of TACE,the amount of lipiodol,and duration of hospital stay after TACE between the two groups.A higher number of patients,specifically 76.2%,were first time TACE receiver in the multimodal group,while in the control group,64.3%of patients have previously received TACE more than one time(Table 1).
图表编号 | XD0020457200 严禁用于非法目的 |
---|---|
绘制时间 | 2018.12.15 |
作者 | Jian-Guo Guo、Lu-Ping Zhao、Yue-Feng Rao、Yin-Ping Gao、Xue-Jiao Guo、Tan-Yang Zhou、Zhi-Ying Feng、Jun-Hui Sun、Xiao-Yang Lu |
绘制单位 | Department of Pain Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine、Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province、Department of Pharmacy, Dongyang People’s Ho |
更多格式 | 高清、无水印(增值服务) |